RECURRENT CANCER
Clinical trials for RECURRENT CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Hard-to-Treat ovarian cancer
Disease control OngoingThis study tests a new drug called CYH33 for women with a certain type of ovarian cancer that has come back. The drug targets a specific gene change (PIK3CA mutation) found in some tumors. About 93 women who have already tried chemotherapy will receive CYH33 to see if it can shri…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New immune drug IMA401 takes on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests IMA401, a new type of immune therapy that helps the body's T cells attack cancer cells. It is for adults with advanced solid tumors (like lung or head/neck cancer) that came back or didn't respond to other treatments. The main goal is to check safety …
Matched conditions: RECURRENT CANCER
Phase: PHASE1 • Sponsor: Immatics Biotechnologies GmbH • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
Nanoparticle-Proton combo for recurrent tumors: study pulled
Disease control TerminatedThis study aimed to test a new treatment for people whose cancer returned in an area already treated with radiation. The approach combined special nanoparticles injected into the blood with proton therapy to target tumors in the head, spine, or pelvis. The goal was to see if this…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC